NICE Funding Wins For Enhertu & Kesimpta Are Firsts For England

More Data Needed Before Enhertu Can Be Made Routinely Available on NHS

England's NHS will pay for new breast cancer drug and MS treatment • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from United Kingdom

More from Europe